Who are Para-Aminosalicylic Acid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Para-Toluenesulfonamide.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/para-aminosalicylic-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Para-Aminosalicylic Acid — Competitive Intelligence Brief

Para-Aminosalicylic Acid (Para-Aminosalicylic Acid) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Bacteriostatic antibiotic. Area: Infectious disease.

phase 3 Bacteriostatic antibiotic Dihydropteroate synthetase Infectious disease Small molecule Live · refreshed every 30 min

Target snapshot

Para-Aminosalicylic Acid (Para-Aminosalicylic Acid) — Beijing Chest Hospital. Para-Aminosalicylic Acid is a bacteriostatic antibiotic that inhibits the synthesis of folate in bacteria.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Para-Aminosalicylic Acid TARGET	Para-Aminosalicylic Acid	Beijing Chest Hospital	phase 3	Bacteriostatic antibiotic	Dihydropteroate synthetase
Para-Toluenesulfonamide	Para-Toluenesulfonamide	Gongwin Biopharm Co., Ltd.	phase 3	Sulfonamide antibiotic	dihydropteroate synthetase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Bacteriostatic antibiotic class)

Beijing Chest Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Para-Aminosalicylic Acid — Competitive Intelligence Brief. https://druglandscape.com/ci/para-aminosalicylic-acid. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab